Tag: Teleflex
Teleflex announce acquisition of Biotronik’s Vascular Intervention business
Teleflex has today announced it has entered into a definitive agreement to acquire Biotronik’s Vascular Intervention business.
The acquisition reflects Teleflex’s commitment to investing...
Interventional News’ top 10 most popular stories of June 2023
Interventional News’ most popular stories from June included a letter from the joint editor-in-chief on the current state of interventional radiology (IR) practice and...
Teleflex announces US FDA clearance of Arrow EZ-IO Needle for use...
Teleflex has announced in a press release that the Arrow EZ-IO Needle is the first and only intraosseous (IO) needle to receive 510(k) clearance from...
Interventional News’ top 10 most popular stories of May 2023
Interventional News’ most popular stories from May included a forecast of where embolization is headed from a Global Embolization Oncology Symposium (GEST, 18–21 May,...
New data show early intervention with UroLift system improves long-term BPH...
Teleflex has announced new research findings reinforcing the long-term durability of prostatic urethral lift (PUL) with the UroLift system and lower complication rates compared...
Teleflex announces collaboration with FundamentalVR to improve training through virtual reality...
Teleflex has announced a new agreement with FundamentalVR, a company providing virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex with...
New data reinforce efficacy of the UroLift system for the treatment...
Teleflex has announced the results of several research studies that further support the safety and efficacy of the UroLift system for men living with...
Teleflex granted reimbursement approval for the “UroLift System” in Japan
Teleflex Incorporated have announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) for the UroLift...
Teleflex announces expanded indications for the Arrow EZ-IO intraosseous vascular access...
Teleflex has announced it has received 510(k) clearance from the US Food and Drug Administration to expand the indications for use of the Arrow...
US FDA grants premarket approval of MANTA vascular closure device
The US Food and Drug Administration (FDA) has given premarket approval (PMA) for the MANTA vascular closure device from Teleflex. This device is the...
12-month data show UroLift system a good treatment option for men...
Twelve-month data from the multicentre prospective MedLift study of the Urolift system (NeoTract, a Teleflex subsidiary) for benign prostatic hyperplasia (BPH) involving a median...
New products showcased at SIR 2018
There were several devices in the New Product Showcase at the Society of Interventional Radiology's Annual Scientific Meeting in Los Angeles, USA. Among these...
Teleflex gets new CEO
Teleflex has announced that it has completed its previously announced senior leadership transition with Liam Kelly succeeding Benson Smith as president and chief executive...
Teleflex completes acquisition of UroLift creator, NeoTract
Teleflex has announced the completion of its previously announced acquisition of NeoTract.
Founded in 2004, NeoTract is a privately-held medical device company that has developed...
Teleflex completes acquisition of Vascular Solutions
Teleflex Incorporated has completed its previously announced acquisition of Vascular Solutions.
On December 2, 2016, the two companies announced a definitive agreement for Teleflex...
Teleflex gets US FDA nod for Arrow VPS Rhythm with optional...
Teleflex has announced that its Arrow VPS Rhythm device with optional TipTracker technology has been issued 510(k) clearance so that the device can be...
Teleflex receives US FDA clearance for Arrow and TightTrack tunneler
Teleflex has announced that it has received US FDA 510(k) clearance to market its Arrow JACC with Chlorag+ard technology and TightTrack tunneler.
Arrow JACC...
